Two Sigma Securities’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-26,831
Closed -$137K 2501
2019
Q4
$137K Buy
+26,831
New +$91.1K ﹤0.01% 2167
2019
Q3
Sell
-12,046
Closed -$26K 2551
2019
Q2
$26K Sell
12,046
-7,374
-38% -$17.4K ﹤0.01% 1928
2019
Q1
$53K Buy
+19,420
New +$84.1K ﹤0.01% 1612
2017
Q4
Sell
-30,289
Closed -$232K 2076
2017
Q3
$232K Buy
+30,289
New +$201K 0.02% 508

Other funds holding IMGN

Two Sigma Securities's IMGN Position: Q1 2020 in Review

Two Sigma Securities sold out of Immunogen Inc (IMGN) in Q1 2020, closing a stake of 26,831 shares — an estimated $137K sold.

Two Sigma Securities first reported a position in IMGN in Q3 2017 and held it in 4 quarters. The position peaked at $232K in Q3 2017. 185 funds tracked by Wall St. Rank hold IMGN as of Q1 2020.

  • Two Sigma Securities reported no remaining Immunogen Inc position as of Q1 2020 after selling out during the quarter.
  • Two Sigma Securities sold 26,831 Immunogen Inc shares in Q1 2020, an estimated $137K.
  • Two Sigma Securities first reported a position in Immunogen Inc in Q3 2017 and held it in 4 quarters.
  • Two Sigma Securities's Immunogen Inc position peaked at $232K in Q3 2017.
  • 185 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2020.

Based on Two Sigma Securities's 13F filing for Q1 2020, filed 15 May 2020.